Search

everythinglearnresearchcommunity

for

Search:↓

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

CD90 is abundantly present on stem-like cells in dog hair follicles.

High DKK1 levels predict worse survival in head and neck cancer.

Revertant cell therapy could be a future treatment for Ichthyosis with confetti.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Farudodstat may effectively treat alopecia areata without harmful side effects.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

A new CDH3 gene mutation was found in a Spanish patient with sparse hair and eye issues.

High TSPEAR levels in colorectal cancer predict worse outcomes.

MAD2B slows down the growth of skin cells that are important for hair development by interacting with TCF4.

circRNA-1926 helps goat stem cells turn into hair follicles by affecting miR-148a/b-3p and CDK19.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Dual TCR Treg cells are common in mouse tissues and vary by location.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

CD44 variant changes start alopecia areata, but don't maintain it.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.